Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-04 @ 5:00 PM
Study NCT ID:
NCT03532451
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2018-05-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Sponsor:
PrECOG, LLC.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PrE0807
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |